Brooklyn Investment Group’s Idexx Laboratories IDXX Stock Holding History

Brooklyn Investment Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.75M	Buy	4,901 +685	+16%	+$439K	0.09%	196
2025 Q4	$2.9M	Buy	4,216 +3,086	+273%	+$2.1M	0.13%	118
2025 Q3	$600K	Buy	1,130 +6	+0.5%	+$3.64K	0.08%	241
2025 Q2	$603K	Buy	1,124 +737	+190%	+$352K	0.08%	249
2025 Q1	$163K	Sell	387 -29	-7%	-$12.6K	0.04%	390
2024 Q4	$172K	Sell	416 -14	-3%	-$6.14K	0.05%	268
2024 Q3	$217K	Sell	430 -3	-0.7%	-$1.46K	0.07%	227
2024 Q2	$231K	Hold	433	–	–	0.1%	206
2024 Q1	$231K	Buy	433 +4	+0.9%	+$2.19K	0.1%	206
2023 Q4	$238K	Buy	+429	New	+$201K	0.11%	190

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brooklyn Investment Group's IDXX Position: Q1 2026 in Review

Brooklyn Investment Group increased its Idexx Laboratories (IDXX) stake by 16% in Q1 2026, buying an estimated $439K and bringing the position to 4,901 shares worth $2.75M. The position accounts for 0.09% of the portfolio, ranked #196.

Brooklyn Investment Group first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.9M in Q4 2025. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Brooklyn Investment Group held 4,901 shares of Idexx Laboratories worth $2.75M as of Q1 2026.
Brooklyn Investment Group bought 685 Idexx Laboratories shares in Q1 2026, an estimated $439K.
Idexx Laboratories made up 0.09% of Brooklyn Investment Group's portfolio in Q1 2026, its #196 holding.
Brooklyn Investment Group first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
Brooklyn Investment Group's Idexx Laboratories position peaked at $2.9M in Q4 2025.
1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.